This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →

Resolved

PIPERACILLIN AND TAZOBACTAM FOR INJECTION

SANDOZ CANADA INCORPORATED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PIPERACILLIN AND TAZOBACTAM FOR INJECTION in Canada?

A shortage of PIPERACILLIN AND TAZOBACTAM FOR INJECTION 4G 0.5G is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 21, 2026), but it has not started yet.

Why is PIPERACILLIN AND TAZOBACTAM FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PIPERACILLIN AND TAZOBACTAM FOR INJECTION be available again?

The estimated resolution date (September 25, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength4G 0.5G

Last updated2026-09-02

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02299658

Strength

4G 0.5G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

PIPERACILLIN TAZOBACTAM

Tier

Unrated

Last Updated

2026-09-02

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

PIPERACILLIN AND TAZOBACTAM FOR INJECTION has 3 shortage/discontinuation reports on file — this is one of them.

2026-09-21

Anticipated Shortage

Disruption of the manufacture of the drug.

2026-09-21

Resolved

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929